Croatia vs Switzerland: Cause of death, by non-communicable diseases, female
Croatia
82.8%
in 2021
Switzerland
83.5%
in 2021
Croatia rank
25th
Switzerland rank
22nd
Cause of death, by non-communicable diseases, female over time
- Croatia
- Switzerland
How they compare
Switzerland currently reports 83.5% against 82.8% in Croatia, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Croatia ahead.
Croatia ranks 25th and Switzerland ranks 22nd of 185 countries.
Croatia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Croatia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.2% | 89.7% | 3.5% | Croatia |
| 2010s | 94.1% | 90.9% | 3.2% | Croatia |
| 2020s | 85.7% | 81.7% | 4.0% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Croatia or Switzerland?
- Switzerland, at 83.5% against 82.8% in Croatia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Croatia and Switzerland?
- 0.7%, with Switzerland ahead.
- How many years of comparable data are there for Croatia and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Croatia and Switzerland rank globally for cause of death, by non-communicable diseases, female?
- Croatia ranks 25th and Switzerland ranks 22nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.